Vida Ventures II LLC 13D/13G Filings for Dyne Therapeutics, Inc. (DYN)

Vida Ventures II LLC 13D and 13G filings for Dyne Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-10
4:31 pm
Sale		2022-08-1513DDyne Therapeutics, Inc.
DYN		Vida Ventures II LLC2,220,034
4.300%		-740,012decrease
(-25.00%)		Filing
2020-10-01
4:41 pm
Purchase		2020-09-2113DDyne Therapeutics, Inc.
DYN		Vida Ventures II LLC2,960,046
6.500%		2,960,046increase
(New Position)		Filing